All lobbying filings
Magill Associates, LLC
Magill Associates, LLC filed a Q2 report for The Livingston Group on Behalf of Innovative Vaccine Technologies on July 7, 2026.
Lobbying for The Livingston Group on Behalf of Innovative Vaccine Technologies · Government and public relations consultants
Filing · LD-2 quarterly report
Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 7, 2026
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
District of Columbia
Lobbyists on this filing
1
-
JOHN PIERSON MAGILLPreviously held: COS to Rep. Wally Herger
Government bodies contacted
2
Lobbying activity
2
FY 2027 appropriations for the development of a synthetic vaccine
FY 2027 appropriations for the development of a synthetic vaccine